387 reports of this reaction
2.3% of all DOFETILIDE reports
#8 most reported adverse reaction
HEADACHE is the #8 most commonly reported adverse reaction for DOFETILIDE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 387 FDA adverse event reports linking DOFETILIDE to HEADACHE. This represents approximately 2.3% of all 17,040 adverse event reports for this drug.
Patients taking DOFETILIDE who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for DOFETILIDE, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for DOFETILIDE:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 387 FDA reports for DOFETILIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.3% of all adverse event reports for DOFETILIDE, making it a notable side effect.
If you experience headache while taking DOFETILIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.